Table 3.
Variable analysis of overall survival after stratifying for stage.
| Variable | Cox-regression analysis |
||
|---|---|---|---|
| p value | HR | 95%CI | |
| Stages I–II | |||
| Association with endometriosis | 0.162 | 0.504 | 0.193–1.318 |
| Serum CA125 > 600 U/mL | 0.725 | 0.834 | 0.304–2.291 |
| Ascites | 0.063 | 2.731 | 0.945–7.889 |
| Chemo-resistance | 0.003* | 4.300 | 1.633–11.323 |
| Residual tumor > 1 cm | 0.040* | 3.479 | 1.062–11.400 |
| Stages III–IV | |||
| Association with endometriosis | 0.037* | 0.068 | 0.005–0.848 |
| Serum CA125 > 600 U/mL | 0.527 | 0.656 | 0.178–2.417 |
| Ascites | 0.481 | 1.779 | 0.359–8.822 |
| Chemo-resistance | 0.007* | 10.120 | 1.882–54.415 |
| Residual tumor > 1 cm | 0.027* | 3.653 | 1.156–11.539 |
*p < 0.05. HR, hazard ratio; CI, confidence interval.